SARTORIUS STED BIO - stock earnings
DIM.PA Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| July 19, 2024 BeforeMarket | - / - | 706.1 million | - / 706.1 million | 706.1 million |
DIM.PA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 56.1 million EUR | 666.9 million EUR |
| 2023Q4 | 39.8 million EUR | 706.8 million EUR |
| 2023Q3 | 25.7 million EUR | 666.9 million EUR |
| 2023Q2 | 133.1 million EUR | 675.7 million EUR |
| 2023Q1 | 111.1 million EUR | 726.1 million EUR |
| 2022Q4 | 186.7 million EUR | 890.0 million EUR |
| 2022Q3 | 204.5 million EUR | 878.4 million EUR |
| 2022Q2 | 214.8 million EUR | 861.8 million EUR |
| 2022Q1 | 270.1 million EUR | 862.5 million EUR |
| 2021Q4 | 8.2 million EUR | 778.2 million EUR |
| 2021Q3 | 147.7 million EUR | 757.0 million EUR |
| 2021Q2 | 144.2 million EUR | 696.7 million EUR |
| 2021Q1 | 114.5 million EUR | 655.2 million EUR |
| 2020Q4 | 114.2 million EUR | 530.7 million EUR |
| 2020Q3 | 101.5 million EUR | 510.4 million EUR |
| 2020Q2 | 67.5 million EUR | 447.0 million EUR |
| 2020Q1 | 75.1 million EUR | 422.1 million EUR |
| 2019Q4 | 55.1 million EUR | 363.9 million EUR |
| 2019Q3 | 58.5 million EUR | 367.4 million EUR |
| 2019Q2 | 64.8 million EUR | 366.4 million EUR |
| 2019Q1 | 56.1 million EUR | 342.9 million EUR |
| 2018Q4 | 67.7 million EUR | 316.1 million EUR |
| 2018Q3 | 49.4 million EUR | 310.4 million EUR |
| 2018Q2 | 50.1 million EUR | 304.6 million EUR |
| 2018Q1 | 40.9 million EUR | 281.1 million EUR |
| 2017Q4 | 44.0 million EUR | 274.5 million EUR |
| 2017Q3 | 37.8 million EUR | 259.7 million EUR |
| 2017Q2 | 39.6 million EUR | 277.9 million EUR |
| 2017Q1 | 39.8 million EUR | 268.8 million EUR |
| 2016Q4 | 34.3 million EUR | 266.5 million EUR |
| 2016Q2 | 39.3 million EUR | 263.0 million EUR |
| 2015Q2 | 32.7 million EUR | 217.6 million EUR |
| 2014Q2 | 18.7 million EUR | 170.2 million EUR |
| 2013Q2 | 20.6 million EUR | 154.6 million EUR |
| 2012Q2 | 12.3 million EUR | 139.1 million EUR |
| 2011Q2 | 9.5 million EUR | 118.8 million EUR |
| 2010Q2 | 9.1 million EUR | 109.1 million EUR |
DIM.PA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 309.7 million EUR | 2.8 billion EUR |
| 2022 | 876.1 million EUR | 3.5 billion EUR |
| 2021 | 414.4 million EUR | 2.9 billion EUR |
| 2020 | 335.9 million EUR | 1.9 billion EUR |
| 2019 | 234.6 million EUR | 1.4 billion EUR |
| 2018 | 208.1 million EUR | 1.2 billion EUR |
| 2017 | 161.1 million EUR | 1.1 billion EUR |
| 2016 | 153.7 million EUR | 1.1 billion EUR |
| 2015 | 118.0 million EUR | 884.3 million EUR |
| 2014 | 72.5 million EUR | 683.5 million EUR |
| 2013 | 66.3 million EUR | 588.4 million EUR |
| 2012 | 56.8 million EUR | 544.0 million EUR |
| 2011 | 43.2 million EUR | 477.3 million EUR |
| 2010 | 38.5 million EUR | 432.9 million EUR |
| 2009 | 29.1 million EUR | 401.2 million EUR |
| 2008 | 13.1 million EUR | 368.0 million EUR |
| 2007 | 4.7 million EUR | 268.8 million EUR |
| 2006 | 29.0 million EUR | 521.1 million EUR |
| 2005 | 22.0 million EUR | 484.3 million EUR |
DIM.PA
Price: €192.15
Forward Dividend Yield: 0.36%
Payout Ratio: 20.54%
Dividend Per Share: 0.69 EUR
Earnings Per Share: 3.35 EUR
P/E Ratio: 50.08
Exchange: PAR
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 19.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 25
DGR3: 30.00%
DGR5: 30.00%
DGR10: 30.00%
DGR20: 30.00%